Evofem Biosciences, Inc. (NASDAQ:EVFM – Get Free Report)’s stock price crossed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $0.01 and traded as high as $0.0102. Evofem Biosciences shares last traded at $0.0102, with a volume of 48,050 shares traded.
Evofem Biosciences Stock Performance
The firm has a market capitalization of $1.29 million, a P/E ratio of -0.02 and a beta of -1.28. The stock’s 50 day simple moving average is $0.01 and its 200 day simple moving average is $0.01.
Evofem Biosciences Company Profile
Evofem Biosciences is a clinical‐stage biotechnology company based in San Diego, California, specializing in women’s sexual and reproductive health. Founded in 2013 as a spin-out of the Scripps Research Institute, the company is focused on developing non-hormonal, on-demand products that address unmet needs in contraception and the prevention of sexually transmitted infections.
The company’s lead commercial product, Phexxi, is an FDA-approved, non-hormonal vaginal gel that maintains the vagina’s natural pH to reduce the risk of unintended pregnancy.
Further Reading
- Five stocks we like better than Evofem Biosciences
- Washington prepares for war
- Put $1,000 into this stock by Jan 1 [Not NVDA]
- Turn your “dead money” into $306+ monthly (starting this month)
- A month before the crash
- Strange Crystal Metal Outperforms Silicon Up to 100X
Receive News & Ratings for Evofem Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evofem Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
